Summary
- Current Price
- As of today, HSIC price is $82.94, down -2.38% on
- Current Price All-Time High
- HSIC price is currently -10.51% below its historical high of $92.68 set on
- Market Cap
- HSIC current market cap is $9B, up +8.52% over the past 365 days
- PE Ratio
- HSIC current PE ratio is 22.69
- Revenue
- HSIC current annual revenue is $13.18B, up +4.03% year-over-year
- Next Earnings
- The next earnings release for HSIC is on
Profile
| Metric | Value |
|---|---|
| Full Name | Henry Schein, Inc. |
| Ticker | NASDAQ: HSIC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Country | United States |
| IPO | |
| Indexes | |
| Website | henryschein.com |
| Employees | 25,000 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $82.94 | |
| Price, 1D Change | -2.38% | |
| Market Cap | $9B | |
| - | ||
| PE Ratio | 22.69 | |
| Beta | 0.64 | |
| Revenue | $13.18B | |
| Revenue, 1Y Change | +4.03% | |
| EPS | $3.27 | |
| EPS, 1Y Change | +7.14% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 51:40 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $3.27 | |
| EPS Estimate | $5.53 | |
| EPS Est. Change | +69.21% | |
| Revenue | $13.18B | |
| Revenue Estimate | $13.84B | |
| Revenue Est. Change | +5.01% | |
| Current Price | $82.94 | |
| Price Target | $100.00 | - |
| Price Tgt. Change | +20.57% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.76 | $3.05 | -35.85% | |
| $4.91 | $3.27 | -33.34% | |
| $5.53 | N/A | +69.21% | |
| $6.01 | N/A | +83.75% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $12.73B | $12.67B | -0.44% | |
| $13.08B | $13.18B | +0.78% | |
| $13.84B | N/A | +5.01% | |
| $14.37B | N/A | +8.98% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +16.41% | |
| Price, 3Y | +20.64% | |
| Market Cap, 1Y | +8.52% | |
| Market Cap, 3Y | +2.63% | |
| Revenue, 1Y | +4.03% | |
| Revenue, 3Y | +4.25% | |
| EPS, 1Y | +7.14% | |
| EPS, 3Y | -16.27% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $82.94 | |
| SMA 200 | $81.61 | |
| SMA 50 | $85.70 | |
| EMA 200 | $82.20 | |
| EMA 50 | $85.85 | |
| MACD | -$0.03 | |
| Beta | 0.64 | |
| ATR | $2.55 | |
| 14-Day RSI | 42.26 | |
| 10-Day Volatility | 48.02% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $13.18B | |
| EPS | $3.27 | |
| Gross Profit | $3.84B | |
| Gross Margin | 29.14% | |
| Operating Income | $758.00M | |
| Operating Margin | 5.75% | |
| Net Income | $419.00M | |
| Net Margin | 3.18% | |
| EBITDA | $1.07B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 1.06 | |
| 1.38 | ||
| 0.76 | ||
| - | ||
| 6 | ||
| 2.80 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 22.69 | |
| 0.67 | ||
| 2.90 | ||
| 11.15 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $3.25B | |
| $156.00M | ||
| $11.22B | ||
| $4.46B | ||
| $6.42B | ||
| $3.23B | ||
| Total Debt | $3.44B | |
| $875.00M | ||
| $1.15B |
Expenses
| Metric | Value | Date |
|---|---|---|
| $12.79B | ||
| $3.08B | ||
| $9.34B | ||
| $0.00 | ||
| $311.00M | ||
| $0.00 | ||
| $126.00M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $712.00M | ||
| -$477.00M | ||
| -$111.00M | ||
| Capex | $191.00M | |
| $521.00M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| UBS | → | |
| Evercore ISI Group | → | |
| Leerink Partners | → | |
| BTIG | → | |
| Barclays | → | |
| UBS | → | |
| Citigroup | → | |
| BTIG | → | |
| Piper Sandler | → | |
| UBS | → |
Analyst sentiment
Institutional ownership
No data
Screeners with HSIC
FAQ
- What is the ticker symbol for Henry Schein, Inc.?
- The ticker symbol for Henry Schein, Inc. is NASDAQ:HSIC
- Does Henry Schein, Inc. pay dividends?
- No, Henry Schein, Inc. does not pay dividends
- What sector is Henry Schein, Inc. in?
- Henry Schein, Inc. is in the Healthcare sector
- What industry is Henry Schein, Inc. in?
- Henry Schein, Inc. is in the Medical Distribution industry
- What country is Henry Schein, Inc. based in?
- Henry Schein, Inc. is headquartered in United States
- When did Henry Schein, Inc. go public?
- Henry Schein, Inc. initial public offering (IPO) was on November 3, 1995
- Is Henry Schein, Inc. in the S&P 500?
- Yes, Henry Schein, Inc. is included in the S&P 500 index
- Is Henry Schein, Inc. in the NASDAQ 100?
- No, Henry Schein, Inc. is not included in the NASDAQ 100 index
- Is Henry Schein, Inc. in the Dow Jones?
- No, Henry Schein, Inc. is not included in the Dow Jones index
- When was Henry Schein, Inc. last earnings report?
- Henry Schein, Inc.'s most recent earnings report was on November 3, 2026
- When does Henry Schein, Inc. report earnings?
- The next expected earnings date for Henry Schein, Inc. is February 23, 2027
Data Sources & References
- HSIC Official Website www.henryschein.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000228/000100022826000013/0001000228-26-000013-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- HSIC Profile on Yahoo Finance finance.yahoo.com/quote/HSIC
- HSIC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/hsic
